DE602006012425D1 - Verfahren zur herstellung einer voll entwickelten natürlichen killerzelle - Google Patents

Verfahren zur herstellung einer voll entwickelten natürlichen killerzelle

Info

Publication number
DE602006012425D1
DE602006012425D1 DE602006012425T DE602006012425T DE602006012425D1 DE 602006012425 D1 DE602006012425 D1 DE 602006012425D1 DE 602006012425 T DE602006012425 T DE 602006012425T DE 602006012425 T DE602006012425 T DE 602006012425T DE 602006012425 D1 DE602006012425 D1 DE 602006012425D1
Authority
DE
Germany
Prior art keywords
natural killer
killer cell
axl
protein
precursor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006012425T
Other languages
English (en)
Inventor
Hyung Sik Kang
Sang Hyun Kim
Eun Mi Kim
Eun Hee Lee
Hee Jung Yun
Chang Bo Ko
Young Jin Heo
Woo Young Shim
Seong Beom Heo
Ji Yeon Yoon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GOOD CELL LIFE Inc
Industry Foundation of Chonnam National University
Original Assignee
GOOD CELL LIFE Inc
Industry Foundation of Chonnam National University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GOOD CELL LIFE Inc, Industry Foundation of Chonnam National University filed Critical GOOD CELL LIFE Inc
Priority claimed from PCT/KR2006/003627 external-priority patent/WO2007032634A1/en
Publication of DE602006012425D1 publication Critical patent/DE602006012425D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0646—Natural killers cells [NK], NKT cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/2307—Interleukin-7 (IL-7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/26—Flt-3 ligand (CD135L, flk-2 ligand)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C12N2501/72—Transferases (EC 2.)
    • C12N2501/727—Kinases (EC 2.7.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/11—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from blood or immune system cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE602006012425T 2005-09-12 2006-09-12 Verfahren zur herstellung einer voll entwickelten natürlichen killerzelle Active DE602006012425D1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
KR1020050084897 2005-09-12
KR1020050084896 2005-09-12
KR1020050084898 2005-09-12
KR1020060070390A KR100650384B1 (ko) 2005-09-12 2006-07-26 성숙자연살해세포의 분화용 조성물 및 그 제조 방법
PCT/KR2006/003627 WO2007032634A1 (en) 2005-09-12 2006-09-12 A method for production of mature natural killer cell

Publications (1)

Publication Number Publication Date
DE602006012425D1 true DE602006012425D1 (de) 2010-04-08

Family

ID=37713748

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006012425T Active DE602006012425D1 (de) 2005-09-12 2006-09-12 Verfahren zur herstellung einer voll entwickelten natürlichen killerzelle

Country Status (4)

Country Link
JP (1) JP2009507827A (de)
KR (1) KR100650384B1 (de)
AT (1) ATE458808T1 (de)
DE (1) DE602006012425D1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009104911A2 (en) * 2008-02-22 2009-08-27 Industry Foundation Of Chonnam National University Uses as agents for prophylaxis or treatment of cervical cancer
CA2839508A1 (en) * 2011-06-22 2012-12-27 Inserm (Institut National De La Sante Et De La Recherche Medicale) Anti-axl antibodies and uses thereof
DE102011106914B4 (de) 2011-07-08 2015-08-27 Zellwerk Gmbh Mäander- Bioreaktor und Verfahren zu dynamischen Expansion, Differenzierung und Ernte von hämatopoetischen Zellen
JP2021509586A (ja) * 2018-01-08 2021-04-01 アイオバンス バイオセラピューティクス，インコーポレイテッド 腫瘍抗原特異的ｔ細胞について濃縮されたｔｉｌ製品を生成するためのプロセス
US11713446B2 (en) 2018-01-08 2023-08-01 Iovance Biotherapeutics, Inc. Processes for generating TIL products enriched for tumor antigen-specific T-cells
CA3112951A1 (en) * 2018-10-01 2020-04-09 Universiteit Gent Accelerated human hematopoietic stem cell differentiation towards mature natural killer cells with enhanced antibody-dependent cytotoxic activity
CN114736859B (zh) * 2022-06-13 2022-08-19 广东先康达生物科技有限公司 一种脐带血nk细胞的培养液及培养方法

Also Published As

Publication number Publication date
KR100650384B1 (ko) 2006-11-30
ATE458808T1 (de) 2010-03-15
JP2009507827A (ja) 2009-02-26

Similar Documents

Publication Publication Date Title
DE602006012425D1 (de) Verfahren zur herstellung einer voll entwickelten natürlichen killerzelle
GB2441718A (en) Differentiation of primate pluripotent stem cells to cardiomyocyte-lineage cells
WO2006017134A3 (en) Preprimitive streak and mesendoderm cells
ATE464799T1 (de) Herstellungsverfahren für eine stange zur herstellung eines raucherartikels
MY162929A (en) Apparatus and methods for controlling cellular development
EP1891990A3 (de) Zusammensetzung und Gerät zur Knochenwiederherstellung
WO2007035363A3 (en) Compositions and methods for the augmentation and repair of defects in tissue
NZ587023A (en) Composition comprising protein and disperse fat
GB2453074A (en) Differentiation of primate pluripotent cells to hepatocyte-lineage cells
EA201290199A1 (ru) Способы и композиции для получения сквалена с применением дрожжей
DE602005023592D1 (de) Endothelvorläuferzellen und verfahren zur verwendung davon
ATE367167T1 (de) Aufbereitung von aldesleukin zur pharmazeutischen verwendung
WO2011099783A3 (ko) 지방조직 유래 줄기세포 및 단핵구로부터 세포성장인자의 생산방법 및 그 이용
EP1721967A4 (de) Verfahren zur differenzierung mesenchymaler stammzellen zu steroidproduzierenden zellen
DE60319599T8 (de) Verfahren zur differenzierung einer mesenchym-stammzelle zu einer nervenzelle sowie die nervenzelle enthaltende pharmazeutische zusammensetzung gegen eine neurodegenerative krankheit
ATE414760T1 (de) Verfahren zur herstellung einer epithelzellen enthaltenden zellzusammensetzung
EP2341147A3 (de) Präprimitivstreifen und mesendoderm- Zellen
WO2008111506A1 (ja) 遺伝子導入細胞調製方法
WO2005054447A3 (en) Müller stem cells
WO2011112976A3 (en) Methods for regenerating skeletal muscle
CN202635192U (zh) 一种新型花盆灯
CN201986545U (zh) 一种微孔陶瓷曝气器
CN102627055A (zh) 一种制作黑白剪贴剪纸艺术品的方法
ATE405633T1 (de) Vorrichtung zur herstellung und handhabung einer fliessenden substanz
CN204443497U (zh) 石斛育种瓶

Legal Events

Date Code Title Description
8364 No opposition during term of opposition